Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis

Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis

Abstract Background This reconstructed individual patient data (IPD)-based meta-analysis is aimed to summarize the current findings and comprehensively investigate the predictive value of circulating tumor DNA (ctDNA) in operable non-small cell lung cancer (NSCLC). Methods PubMed, Cochrane and Embas...

Full description

Bibliographic Details
Main Authors:	Dali Chen, Jinbao Guo, Hao Huang, Lei Tian, Yunbo Xie, Qingchen Wu
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	BMC Medicine
Subjects:	Non-small cell lung cancer Circulating tumor DNA Disease-free survival Meta-analysis Individual patient data
Online Access:	https://doi.org/10.1186/s12916-023-03181-2

Similar Items

Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis
by: Farzana Y. Zaman, et al.
Published: (2023-04-01)

Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
by: Woo Kyung Ryu, et al.
Published: (2022-08-01)

The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
by: Binliang Liu, et al.
Published: (2022-10-01)

Detecting circulating microbial cell-free DNA by next-generation sequencing in patients with Mycobacterium avium complex-lung disease: A pilot study
by: Yen-Han Tseng, et al.
Published: (2024-01-01)

Meta-Analysis of Circulating Cell-Free DNA’s Role in the Prognosis of Pancreatic Cancer
by: Jelena Milin-Lazovic, et al.
Published: (2021-07-01)

The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer
by: Alberto Verlicchi, et al.
Published: (2023-09-01)

Evaluate the Prognostic Value of Non–Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA: A Systematic Review and Meta-analysis
by: Negar Eghbalifard, et al.
Published: (2024-03-01)

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
by: Suzanna J. Schraa, et al.
Published: (2022-04-01)

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
by: Preawwalee Wintachai, et al.
Published: (2021-05-01)

Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma
by: Yifan Chen, et al.
Published: (2023-06-01)

The Prognostic Utility of <i>KRAS</i> Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients
by: Joel Petit, et al.
Published: (2024-01-01)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01)

A Pilot Study of Circulating Tumor Cells in Stage IV Non-Small Cell Lung Carcinoma
by: Max Haid, et al.
Published: (2016-08-01)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
by: Li-Yue Sun, et al.
Published: (2021-02-01)

Circulating free DNA in hypertensive patients with high cardiovascular risk
by: E. A. Trofimova, et al.
Published: (2022-05-01)

Liquid Biopsy in Small Cell Lung Cancer—A Route to Improved Clinical Care?
by: Matt Church, et al.
Published: (2020-12-01)

Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population
by: Shai Rosenberg, et al.
Published: (2023-09-01)

Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
by: Anna Citarella, et al.
Published: (2023-09-01)

Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer
by: Siwei Wang, et al.
Published: (2022-10-01)

The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA
by: Tenna V. Henriksen, et al.
Published: (2020-08-01)

Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis
by: Morten Borg, et al.
Published: (2023-08-01)

Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges
by: Bryan Ulrich, et al.
Published: (2021-07-01)

CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data
by: Johannes Wach, et al.
Published: (2023-11-01)

Advances in diagnosis and evaluation of lymphoma through the detection of circulating cell free DNA
by: BAI Xiao-teng, SUN Xiao-hong, ZHAO Xiang-yu, LI Zi-jian
Published: (2022-04-01)

Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients
by: Natalia Galant, et al.
Published: (2024-02-01)

Circulating tumor DNA, a new tool for diagnosing and monitoring cancer patients?
by: Bente Risberg, et al.
Published: (2016-01-01)

Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
by: Miles W. Grunvald, et al.
Published: (2020-10-01)

A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma
by: Weiqing Wang, et al.
Published: (2022-03-01)

Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix<sup>®</sup> System
by: Gabrielle Wishart, et al.
Published: (2024-01-01)

The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
by: Nicole Laurencia Yuwono, et al.
Published: (2021-11-01)

Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer
by: Wei-Wei Peng, et al.
Published: (2023-09-01)

Prognostic value of perineural invasion in resected non-small cell lung cancer: A meta-analysis
by: Wenliang Liu, et al.
Published: (2023-04-01)

Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients
by: Evelyn Adusei, et al.
Published: (2021-05-01)

Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice
by: Kyung-Hee Kim, et al.
Published: (2023-04-01)

Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR‐TKI treatment in advanced non‐small cell lung cancer
by: Jie Zheng, et al.
Published: (2022-11-01)

Epigenetic «probes» for lung cancer monitoring: LINE-1 methylation pattern in blood- circulating DNA
by: A. A. Ponomaryova, et al.
Published: (2015-07-01)

Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study
by: Andrew Condappa, et al.
Published: (2020-09-01)

Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses
by: Jan M. van Rees, et al.
Published: (2023-01-01)

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
by: Paul van der Leest, et al.
Published: (2023-08-01)

Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC
by: Jun Wu, et al.
Published: (2023-05-01)